Also, β-catenin/BCL2 and β-catenin/HSP90 interaction were found to be significantly related to enhanced HCC patients’ survival, where (β-catenin−/BCL2−) samples had better survival chances compared to (β-catenin+/BCL2+). This evidence concerns the gene BCL2 and hepatocellular carcinoma.